Cresemba
Cresemba Granted Pediatric Indication for Invasive Aspergillosis and Mycormycosis
The FDA expanded the indication for Cresemba, an azole antifungal, to treat invasive aspergillosis and mucormycosis ...
DECEMBER 12, 2023
Early Diagnosis Vital To Defeating (Often) Deadly Fungus
Mortality rate for immunocompromised individuals with invasive aspergillosis is 40% or higher.
JUNE 30, 2016
Load more